This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: JNPR MFRM RBC SUSS WETF


(ICE) was upgraded to buy at TheStreet Ratings.

(JNPR - Get Report) was upgraded at Wells Fargo to outperform from market perform. New CEO can help the company leverage higher enterprise demand in the coming quarters, Wells Fargo said.

Mattress Firm (MFRM) was initiated at Jefferies with a buy rating. Unit growth story with positive new store economics, Jefferies said. Twelve-month price target is $56.

Regal-Beloit (RBC) was upgraded at Robert Baird to outperform from neutral. Valuation call, based on a 12-month price target of $87.

Sterling Bancorp (STL) was upgraded to buy at TheStreet Ratings.

Susser Petroleum (SUSS) was initiated at Jefferies with a hold rating. Valuation call, with positive foodservice story and 4%-5% store growth, Jefferies said. Twelve-month price target is $72.

Teva (TEVA) was upgraded at Goldman Sachs to neutral from sell. Copaxone slowdown is largely priced in and the underlying business can deliver growth, Goldman Sachs said. Twelve-month price target is $52.

Must Read: Analysts' Actions: LLL MKTO NBR UHS UMPQ

Wisdomtree (WETF - Get Report) was downgraded at Citigroup to sell from neutral. Twelve-month price target is $11. Estimates were also cut, given lower expected organic growth, Citigroup said.

Stock Comments / EPS Changes

AbbVie (ABBV) price target was lowered at Jefferies. Competitive data in Hep C, pay for delay litigation re Androgel, Jefferies said. Twelve-month price target is $60.

Abbott (ABT) price target was cut at Jefferies. Pricing pressure in EPD, MD pricing/volume pressure and FX exposure, Jefferies said. Twelve-month price target is now $45. Buy rating.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
JNPR $23.41 0.00%
WETF $11.83 0.00%
AAPL $95.03 0.21%
FB $116.73 0.00%
GOOG $691.02 0.00%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs